At AAL Biosciences, we help medical device innovators establish biological safety with precision and confidence.

Our comprehensive Biocompatibility & Safety Testing services, conducted in accordance with the ISO 10993 series, evaluate how devices and materials interact with the human body, ensuring patient safety, product reliability, and regulatory compliance.

With GLP-compliant infrastructure, advanced facilities, and a team of ABT-certified toxicologists, AAL delivers dependable data for global submissions, including FDA, EU MDR, and CDSCO. At our lab, we conduct an extensive range of biocompatibility evaluations that determine systemic, local, and cellular responses to medical devices and materials.

Here is why biocompatibility & safety testing are pivotal in medical device testing:

• • Ensures Patient Safety: Confirms that medical devices are non-toxic, non-irritant, and safe for intended contact with the body.
  • Supports Regulatory Approvals: Provides the scientific evidence required to comply with ISO 10993, USP, FDA, and EU MDR standards.
  • Validates Material Selection: Helps identify safe and biocompatible materials early in the design phase, reducing costly redesigns.
  • Predicts Long-Term Biological Responses: Evaluates chronic and systemic effects to ensure performance and safety throughout the product lifecycle.
  • Builds Market Confidence: Demonstrates a proven commitment to quality, ethics, and patient well-being, strengthening brand credibility.